Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025
On Monday, Cathie Wood-led Ark Invest made significant trades in five major companies: Palantir Technologies Inc. (NASDAQ:PLTR), Tempus AI Inc. (NASDAQ:TEM), CareDx Inc. (NASDAQ:CDNA), Veracyte Inc. (NASDAQ:VCYT), Adaptive Biotechnologies Corp. (NASDAQ:ADPT).
The PLTR Trade
Ark Invest’s Ark Innovation ETF (NYSE:ARKK) fund sold 140,518 shares of Palantir. This move is significant, considering Ark Invest’s recent trend of offloading Palantir shares.
The total value of this trade, based on the latest closing price of $64.98, is approximately $9.1 million.
This sale follows Ark’s disposal of shares worth roughly $15 million the previous week.
Palantir stock price has fallen more than 14% over the past month. In just the first two weeks of 2025, the stock has declined nearly 15%.
The TEM Trade
Ark Invest’s ARK Genomic Revolution ETF (BATS:ARKG) and ARKK funds made substantial purchases of Tempus AI Inc. shares. The ARKG fund bought 98,691 shares, while the ARKK fund purchased a whopping 280,192 shares.
Given the latest closing price of $32.34, the total value of these trades amounts to approximately $12.2 million.
This move comes amid TEM’s 13.81% drop on Monday.
Other Key Trades:
Company
ETF
Transaction
No. Of Shares
Closing price
Approx. Value
Veracyte Inc. (NASDAQ:VCYT)
ARK Genomic Revolution
Sale
37,358
$42.78
$1.6 million
Adaptive Biotechnologies Corp. (NASDAQ:ADPT)
ARK Genomic Revolution
Sale
76,522
$6.46
$494,332
CareDx Inc. (NASDAQ:CDNA)
ARK Genomic Revolution
Sale
65,550
$25.07
$1.6 million
Closing price as of Jan. 13, 2025
Read Next:
Image via Benzinga YouTube and Unsplash
This story was generated using Benzinga Neuro and edited by Rounak Jain
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: ARK Invest Ark Invest Management Cathie WoodEquities News Markets Tech ETFs
